Use of triazoles for the treatment of invasive aspergillosis: A three‐year cohort analysis. Issue 1 (30th October 2019)

• Record Type: Journal Article
• Authors: Cheng, Matthew P.; Orejas, José L.; Arbona‐Haddad, Esther; Bold, Tyler D.; Solomon, Isaac H.; Chen, Kaiwen; Pandit, Alisha; Kusztos, Amanda E.; Cummins, Kaelyn C.; Liakos, Alexis; Marty, Francisco M.; Koo, Sophia; Hammond, Sarah P.
• Is Part Of: Mycoses. Volume 63:Issue 1(2020)
• Page Start: 58
• Page End: 64
• Publication Date: 2019-10-30
• Subjects: Aspergillus -- invasive aspergillosis -- isavuconazole -- posaconazole -- voriconazole; Pathogenic fungi -- Periodicals; Medical mycology -- Periodicals; 616.969
• DOI: 10.1111/myc.13013
• Languages: English
• ISSNs: 0933-7407

Abstract

Summary: In a 3‐year cohort study of adult patients with proven or probable IA, fewer patients initially treated with isavuconazole experienced adverse events compared with voriconazole, but more patients required a change in therapy due to lack of clinical efficacy.